Literature DB >> 33238112

Endosomal Dysfunction Induced by Directly Overactivating Rab5 Recapitulates Prodromal and Neurodegenerative Features of Alzheimer's Disease.

Anna Pensalfini1, Seonil Kim2, Shivakumar Subbanna3, Cynthia Bleiwas4, Chris N Goulbourne5, Philip H Stavrides5, Ying Jiang1, Ju-Hyun Lee1, Sandipkumar Darji5, Monika Pawlik5, Chunfeng Huo5, James Peddy5, Martin J Berg5, John F Smiley4, Balapal S Basavarajappa6, Ralph A Nixon7.   

Abstract

Neuronal endosomal dysfunction, the earliest known pathobiology specific to Alzheimer's disease (AD), is mediated by the aberrant activation of Rab5 triggered by APP-β secretase cleaved C-terminal fragment (APP-βCTF). To distinguish pathophysiological consequences specific to overactivated Rab5 itself, we activate Rab5 independently from APP-βCTF in the PA-Rab5 mouse model. We report that Rab5 overactivation alone recapitulates diverse prodromal and degenerative features of AD. Modest neuron-specific transgenic Rab5 expression inducing hyperactivation of Rab5 comparable to that in AD brain reproduces AD-related Rab5-endosomal enlargement and mistrafficking, hippocampal synaptic plasticity deficits via accelerated AMPAR endocytosis and dendritic spine loss, and tau hyperphosphorylation via activated glycogen synthase kinase-3β. Importantly, Rab5-mediated endosomal dysfunction induces progressive cholinergic neurodegeneration and impairs hippocampal-dependent memory. Aberrant neuronal Rab5-endosome signaling, therefore, drives a pathogenic cascade distinct from β-amyloid-related neurotoxicity, which includes prodromal and neurodegenerative features of AD, and suggests Rab5 overactivation as a potential therapeutic target.
Copyright © 2020 The Authors. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Alzheimer’s disease; Rab5 hyperactivation; aberrant endosomal signaling; amyloid precursor protein; cholinergic neurodegeneration; endosomal dysfunction; memory impairment; spine loss; synaptic deficits; tau

Mesh:

Substances:

Year:  2020        PMID: 33238112      PMCID: PMC7714675          DOI: 10.1016/j.celrep.2020.108420

Source DB:  PubMed          Journal:  Cell Rep            Impact factor:   9.423


  116 in total

Review 1.  Dysregulation of Rab5-mediated endocytic pathways in Alzheimer's disease.

Authors:  Wei Xu; Fang Fang; Jianqing Ding; Chengbiao Wu
Journal:  Traffic       Date:  2018-02-05       Impact factor: 6.215

2.  Increased App expression in a mouse model of Down's syndrome disrupts NGF transport and causes cholinergic neuron degeneration.

Authors:  Ahmad Salehi; Jean-Dominique Delcroix; Pavel V Belichenko; Ke Zhan; Chengbiao Wu; Janice S Valletta; Ryoko Takimoto-Kimura; Alexander M Kleschevnikov; Kumar Sambamurti; Peter P Chung; Weiming Xia; Angela Villar; William A Campbell; Laura Shapiro Kulnane; Ralph A Nixon; Bruce T Lamb; Charles J Epstein; Gorazd B Stokin; Lawrence S B Goldstein; William C Mobley
Journal:  Neuron       Date:  2006-07-06       Impact factor: 17.173

Review 3.  Apolipoprotein E and Alzheimer disease: risk, mechanisms and therapy.

Authors:  Chia-Chen Liu; Chia-Chan Liu; Takahisa Kanekiyo; Huaxi Xu; Guojun Bu
Journal:  Nat Rev Neurol       Date:  2013-01-08       Impact factor: 42.937

4.  Indirubin-3'-monoxime prevents aberrant activation of GSK-3β/NF-κB and alleviates high fat-high fructose induced Aβ-aggregation, gliosis and apoptosis in mice brain.

Authors:  C Sathiya Priya; R Vidhya; K Kalpana; C V Anuradha
Journal:  Int Immunopharmacol       Date:  2019-03-08       Impact factor: 4.932

5.  Loss of Bin1 Promotes the Propagation of Tau Pathology.

Authors:  Sara Calafate; William Flavin; Patrik Verstreken; Diederik Moechars
Journal:  Cell Rep       Date:  2016-10-18       Impact factor: 9.423

6.  Endocytic pathway abnormalities precede amyloid beta deposition in sporadic Alzheimer's disease and Down syndrome: differential effects of APOE genotype and presenilin mutations.

Authors:  A M Cataldo; C M Peterhoff; J C Troncoso; T Gomez-Isla; B T Hyman; R A Nixon
Journal:  Am J Pathol       Date:  2000-07       Impact factor: 4.307

7.  Purification and identification of novel Rab effectors using affinity chromatography.

Authors:  S Christoforidis; M Zerial
Journal:  Methods       Date:  2000-04       Impact factor: 3.608

8.  A hexanucleotide repeat expansion in C9ORF72 is the cause of chromosome 9p21-linked ALS-FTD.

Authors:  Alan E Renton; Elisa Majounie; Adrian Waite; Javier Simón-Sánchez; Sara Rollinson; J Raphael Gibbs; Jennifer C Schymick; Hannu Laaksovirta; John C van Swieten; Liisa Myllykangas; Hannu Kalimo; Anders Paetau; Yevgeniya Abramzon; Anne M Remes; Alice Kaganovich; Sonja W Scholz; Jamie Duckworth; Jinhui Ding; Daniel W Harmer; Dena G Hernandez; Janel O Johnson; Kin Mok; Mina Ryten; Danyah Trabzuni; Rita J Guerreiro; Richard W Orrell; James Neal; Alex Murray; Justin Pearson; Iris E Jansen; David Sondervan; Harro Seelaar; Derek Blake; Kate Young; Nicola Halliwell; Janis Bennion Callister; Greg Toulson; Anna Richardson; Alex Gerhard; Julie Snowden; David Mann; David Neary; Michael A Nalls; Terhi Peuralinna; Lilja Jansson; Veli-Matti Isoviita; Anna-Lotta Kaivorinne; Maarit Hölttä-Vuori; Elina Ikonen; Raimo Sulkava; Michael Benatar; Joanne Wuu; Adriano Chiò; Gabriella Restagno; Giuseppe Borghero; Mario Sabatelli; David Heckerman; Ekaterina Rogaeva; Lorne Zinman; Jeffrey D Rothstein; Michael Sendtner; Carsten Drepper; Evan E Eichler; Can Alkan; Ziedulla Abdullaev; Svetlana D Pack; Amalia Dutra; Evgenia Pak; John Hardy; Andrew Singleton; Nigel M Williams; Peter Heutink; Stuart Pickering-Brown; Huw R Morris; Pentti J Tienari; Bryan J Traynor
Journal:  Neuron       Date:  2011-09-21       Impact factor: 17.173

9.  Characterization of the early endosome and putative endocytic carrier vesicles in vivo and with an assay of vesicle fusion in vitro.

Authors:  J Gruenberg; G Griffiths; K E Howell
Journal:  J Cell Biol       Date:  1989-04       Impact factor: 10.539

10.  Amino acids stimulate the endosome-to-Golgi trafficking through Ragulator and small GTPase Arl5.

Authors:  Meng Shi; Bing Chen; Divyanshu Mahajan; Boon Kim Boh; Yan Zhou; Bamaprasad Dutta; Hieng Chiong Tie; Siu Kwan Sze; Geng Wu; Lei Lu
Journal:  Nat Commun       Date:  2018-11-26       Impact factor: 14.919

View more
  18 in total

1.  Assessing Rab5 Activation in Health and Disease.

Authors:  Anna Pensalfini; Ying Jiang; Seonil Kim; Ralph A Nixon
Journal:  Methods Mol Biol       Date:  2021

2.  An isogenic panel of App knock-in mouse models: Profiling β-secretase inhibition and endosomal abnormalities.

Authors:  Naoto Watamura; Kaori Sato; Gen Shiihashi; Ayami Iwasaki; Naoko Kamano; Mika Takahashi; Misaki Sekiguchi; Naomi Mihira; Ryo Fujioka; Kenichi Nagata; Shoko Hashimoto; Takashi Saito; Toshio Ohshima; Takaomi C Saido; Hiroki Sasaguri
Journal:  Sci Adv       Date:  2022-06-08       Impact factor: 14.957

3.  Neuronal Rubicon Represses Extracellular APP/Amyloid β Deposition in Alzheimer's Disease.

Authors:  Sandra Espinoza; Felipe Grunenwald; Wileidy Gomez; Felipe García; Lorena Abarzúa-Catalan; Sebastián Oyarce-Pezoa; Maria Fernanda Hernandez; Bastián I Cortés; Markus Uhrig; Daniela P Ponce; Claudia Durán-Aniotz; Claudio Hetz; Carol D SanMartín; Victor H Cornejo; Fernando Ezquer; Valentina Parra; Maria Isabel Behrens; Patricio A Manque; Diego Rojas-Rivera; René L Vidal; Ute Woehlbier; Melissa Nassif
Journal:  Cells       Date:  2022-06-07       Impact factor: 7.666

4.  Impact of increased APP gene dose in Down syndrome and the Dp16 mouse model.

Authors:  Mariko Sawa; Cassia Overk; Ann Becker; Dominique Derse; Ricardo Albay; Kim Weldy; Ahmad Salehi; Thomas G Beach; Eric Doran; Elizabeth Head; Y Eugene Yu; William C Mobley
Journal:  Alzheimers Dement       Date:  2021-11-10       Impact factor: 16.655

5.  NHE6 depletion corrects ApoE4-mediated synaptic impairments and reduces amyloid plaque load.

Authors:  Theresa Pohlkamp; Xunde Xian; Connie H Wong; Murat S Durakoglugil; Gordon Chandler Werthmann; Takaomi C Saido; Bret M Evers; Charles L White; Jade Connor; Robert E Hammer; Joachim Herz
Journal:  Elife       Date:  2021-10-07       Impact factor: 8.713

6.  BAG3 Regulation of RAB35 Mediates the Endosomal Sorting Complexes Required for Transport/Endolysosome Pathway and Tau Clearance.

Authors:  Heng Lin; Maoping Tang; Changyi Ji; Peter Girardi; Gregor Cvetojevic; Daniel Chen; Shon A Koren; Gail V W Johnson
Journal:  Biol Psychiatry       Date:  2021-11-10       Impact factor: 12.810

7.  The Alzheimer susceptibility gene BIN1 induces isoform-dependent neurotoxicity through early endosome defects.

Authors:  Erwan Lambert; Orthis Saha; Marcos R Costa; Pierre Dourlen; Bruna Soares Landeira; Ana Raquel Melo de Farias; Xavier Hermant; Arnaud Carrier; Alexandre Pelletier; Johanna Gadaut; Lindsay Davoine; Cloé Dupont; Philippe Amouyel; Amélie Bonnefond; Frank Lafont; Farida Abdelfettah; Patrik Verstreken; Julien Chapuis; Nicolas Barois; Fabien Delahaye; Bart Dermaut; Jean-Charles Lambert
Journal:  Acta Neuropathol Commun       Date:  2022-01-08       Impact factor: 7.801

8.  Alzheimer's vulnerable brain region relies on a distinct retromer core dedicated to endosomal recycling.

Authors:  Sabrina Simoes; Jia Guo; Luna Buitrago; Yasir H Qureshi; Xinyang Feng; Milankumar Kothiya; Etty Cortes; Vivek Patel; Suvarnambiga Kannan; Young-Hyun Kim; Kyu-Tae Chang; S Abid Hussaini; Herman Moreno; Gilbert Di Paolo; Olav M Andersen; Scott A Small
Journal:  Cell Rep       Date:  2021-12-28       Impact factor: 9.423

Review 9.  Crossroads between membrane trafficking machinery and copper homeostasis in the nerve system.

Authors:  Meng-Hsuan Wen; Xihong Xie; Pei-San Huang; Karen Yang; Tai-Yen Chen
Journal:  Open Biol       Date:  2021-12-01       Impact factor: 6.411

10.  Interruption of endolysosomal trafficking leads to stroke brain injury.

Authors:  Dong Yuan; Kurt Hu; Chun Mun Loke; Hironori Teramoto; Chunli Liu; Bingren Hu
Journal:  Exp Neurol       Date:  2021-08-05       Impact factor: 5.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.